| |
| |
|
| Insider
Information: |
Kliman Gilbert H |
| Relationship: |
See remarks |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
4,973,231 |
|
|
Indirect Shares
|
793,165 |
|
|
| Direct
Value |
$14,299,487 |
|
|
|
Indirect Value
|
$148,198 |
|
|
| Total
Shares |
5,766,396 |
|
|
| Total
Value |
$14,447,685 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
10
|
|
Stock
price went up :
|
1
|
4
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 80.0%
|
 -120.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anesiva Inc |
ANSVQ |
10% Owner |
2006-03-17 |
12,283 |
2006-03-17 |
21,869 |
Premium* |
|
|
Epocrates Inc |
EPOC |
Former 10% Owner, Dire... |
2011-02-07 |
0 |
2011-02-07 |
87,087 |
Premium* |
|
|
Glaukos Corp |
GKOS |
|
2024-03-07 |
30,620 |
2024-03-06 |
0 |
Premium* |
|
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2017-10-16 |
0 |
2019-11-07 |
658,657 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
Director |
2023-12-01 |
10,457 |
2020-06-01 |
0 |
Premium* |
|
|
Pmv Pharmaceuticals, Inc. |
PMVP |
10% Owner |
2021-07-13 |
4,469,911 |
2021-07-13 |
25,552 |
Premium* |
|
|
Doximity, Inc. |
DOCS |
See remarks |
2022-08-02 |
449,960 |
2021-12-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GKOS |
Glaukos Corp |
|
– • – |
2024-03-07 |
4 |
S |
$88.25 |
$441,250 |
D/D |
(5,000) |
30,620 |
0 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-03-07 |
4 |
OE |
$32.00 |
$160,000 |
D/D |
5,000 |
35,620 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-03-06 |
4 |
S |
$84.93 |
$712,307 |
I/I |
(8,347) |
0 |
0 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-02-27 |
4 |
S |
$92.00 |
$736,000 |
I/I |
(8,000) |
8,347 |
0 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
30,620 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-12-01 |
4 |
A |
$32.99 |
$12,074 |
D/D |
366 |
10,457 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-09-29 |
4 |
A |
$40.18 |
$17,478 |
D/D |
435 |
10,091 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-08-04 |
4 |
S |
$74.56 |
$745,600 |
D/D |
(10,000) |
29,725 |
0 |
% |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-08-04 |
4 |
OE |
$7.28 |
$72,750 |
D/D |
10,000 |
39,725 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2023-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,417 |
9,656 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,230 |
29,725 |
0 |
- |
|
| GKOS |
Glaukos Corp |
|
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
26,495 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-08-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,382 |
16,347 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-08-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,382) |
24,923 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-08-05 |
4 |
S |
$53.01 |
$178,229 |
I/I |
(3,362) |
0 |
0 |
% |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-08-04 |
4 |
A |
$0.00 |
$0 |
I/I |
83,955 |
83,955 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-08-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(417,872) |
0 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
19,045 |
27,305 |
0 |
- |
|
| DOCS |
Doximity, Inc. |
See remarks |
– – – |
2022-08-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,714) |
449,960 |
0 |
- |
|
| DOCS |
Doximity, Inc. |
Director |
– • – |
2022-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,714 |
454,674 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
Director |
– • – |
2022-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,254 |
6,239 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,364 |
8,260 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
980 |
13,965 |
0 |
- |
|
| GKOS |
Glaukos Corp |
Director |
– • – |
2022-05-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(980) |
3,896 |
0 |
- |
|
| DOCS |
Doximity, Inc. |
Director |
– • – |
2022-02-25 |
4 |
S |
$59.00 |
$48,734 |
D/D |
(826) |
449,960 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
